SM
ALBO

Sabby Management’s Albireo Pharma Inc ALBO Stock Holding History

Sabby Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11,917
Closed -$118K – 347
2016
Q1 		$118K Sell
11,917
-37,441
-76% -$333K 0.01% 274
2015
Q4 		$507K Buy
49,358
+16,569
+51% +$171K 0.03% 235
2015
Q3 		$433K Sell
32,789
-5,524
-14% -$139K 0.02% 306
2015
Q2 		$1.18M Buy
38,313
+31,063
+428% +$1.04M 0.04% 209
2015
Q1 		$259K Sell
7,250
-46,588
-87% -$1.96M 0.01% 260
2014
Q4 		$2.15M Buy
53,838
+4,078
+8% +$179K 0.07% 118
2014
Q3 		$2.49M Buy
49,760
+41,740
+520% +$2.4M 0.1% 95
2014
Q2 		$520K Buy
+8,020
New +$558K 0.02% 190

Other funds holding ALBO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sabby Management's ALBO Position: Q2 2016 in Review

Sabby Management sold out of Albireo Pharma Inc (ALBO) in Q2 2016, closing a stake of 11,917 shares — an estimated $118K sold.

Sabby Management first reported a position in ALBO in Q2 2014 and held it in 8 quarters. The position peaked at $2.49M in Q3 2014. 24 funds tracked by Wall St. Rank hold ALBO as of Q2 2016.

  • Sabby Management reported no remaining Albireo Pharma Inc position as of Q2 2016 after selling out during the quarter.
  • Sabby Management sold 11,917 Albireo Pharma Inc shares in Q2 2016, an estimated $118K.
  • Sabby Management first reported a position in Albireo Pharma Inc in Q2 2014 and held it in 8 quarters.
  • Sabby Management's Albireo Pharma Inc position peaked at $2.49M in Q3 2014.
  • 24 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2016.

Based on Sabby Management's 13F filing for Q2 2016, filed 15 Aug 2016.